Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome
William S. Baldwin, Steven McRae, George Marek, et al.
Diabetes (2011) Vol. 60, Iss. 4, pp. 1258-1269
Open Access | Times Cited: 414

Showing 1-25 of 414 citing articles:

Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen, Manal F. Abdelmalek, Shelby Sullivan, et al.
Journal of Hepatology (2018) Vol. 68, Iss. 5, pp. 1063-1075
Open Access | Times Cited: 786
Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
Richard J. Johnson, Takahiko Nakagawa, Laura Gabriela Sánchez‐Lozada, et al.
Diabetes (2013) Vol. 62, Iss. 10, pp. 3307-3315
Open Access | Times Cited: 694
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress
Miguel A. Lanaspa, Laura Gabriela Sánchez‐Lozada, Yea-Jin Choi, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 48, pp. 40732-40744
Open Access | Times Cited: 619
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
Richard J. Johnson, George L. Bakris, Claudio Borghi, et al.
American Journal of Kidney Diseases (2018) Vol. 71, Iss. 6, pp. 851-865
Open Access | Times Cited: 533
The pathophysiology of hypertension in patients with obesity
Vincent G. DeMarco, Annayya R. Aroor, James R. Sowers
Nature Reviews Endocrinology (2014) Vol. 10, Iss. 6, pp. 364-376
Open Access | Times Cited: 468
Metabolic syndrome, diabetes, and hyperuricemia
Changgui Li, Ming‐Chia Hsieh, Shun‐Jen Chang
Current Opinion in Rheumatology (2013) Vol. 25, Iss. 2, pp. 210-216
Closed Access | Times Cited: 406
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan, Grzegorz Godlewski, Reşat Çınar, et al.
Nature Medicine (2013) Vol. 19, Iss. 9, pp. 1132-1140
Open Access | Times Cited: 365
Uric acid in metabolic syndrome: From an innocent bystander to a central player
Mehmet Kanbay, Thomas Jensen, Yalçın Solak, et al.
European Journal of Internal Medicine (2015) Vol. 29, pp. 3-8
Open Access | Times Cited: 361
Animal models of metabolic syndrome: a review
Sok Kuan Wong, Kok‐Yong Chin, Farihah Hj Suhaimi, et al.
Nutrition & Metabolism (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 327
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Jan‐Bernd Funcke, Philipp E. Scherer
Journal of Lipid Research (2019) Vol. 60, Iss. 10, pp. 1648-1697
Open Access | Times Cited: 261
The Inflammasome Puts Obesity in the Danger Zone
Rinke Stienstra, Cees J. Tack, Thirumala‐Devi Kanneganti, et al.
Cell Metabolism (2012) Vol. 15, Iss. 1, pp. 10-18
Open Access | Times Cited: 259
Macrophage functions in lean and obese adipose tissue
Dylan Thomas, Caroline M. Apovian
Metabolism (2017) Vol. 72, pp. 120-143
Open Access | Times Cited: 254
Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
Yunes Panahi, Parisa Kianpour, Reza Mohtashami, et al.
Journal of Cardiovascular Pharmacology (2016) Vol. 68, Iss. 3, pp. 223-229
Closed Access | Times Cited: 228
Uric acid as a modulator of glucose and lipid metabolism
William Gustavo Lima, Maria Emília Soares Martins-Santos, Valéria Ernestânia Chaves
Biochimie (2015) Vol. 116, pp. 17-23
Closed Access | Times Cited: 228
Contribution of uric acid to cancer risk, recurrence, and mortality
Mehdi A. Fini, A. Elias, Richard J. Johnson, et al.
Clinical and Translational Medicine (2012) Vol. 1, Iss. 1
Open Access | Times Cited: 216
Uric Acid - Key Ingredient in the Recipe for Cardiorenal Metabolic Syndrome
Kunal Chaudhary, Kunal Malhotra, James R. Sowers, et al.
Cardiorenal Medicine (2013) Vol. 3, Iss. 3, pp. 208-220
Open Access | Times Cited: 214
Relationship between Hyperuricemia and Lipid Profiles in US Adults
Tao‐Chun Peng, Chung‐Ching Wang, Tung‐Wei Kao, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-7
Open Access | Times Cited: 207
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality
David Gustafsson, Robert J. Unwin
BMC Nephrology (2013) Vol. 14, Iss. 1
Open Access | Times Cited: 206
The role of xanthine oxidoreductase and uric acid in metabolic syndrome
Maria Giulia Battelli, Massimo Bortolotti, Letizia Polito, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 8, pp. 2557-2565
Open Access | Times Cited: 178
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
Yuka Sato, Daniel I. Feig, Austin G. Stack, et al.
Nature Reviews Nephrology (2019) Vol. 15, Iss. 12, pp. 767-775
Closed Access | Times Cited: 163
Identifying top ten predictors of type 2 diabetes through machine learning analysis of UK Biobank data
Moa Lugner, Araz Rawshani, Edvin Helleryd, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey
Jeffrey C. Sirota, Kim McFann, Giovanni Targher, et al.
Metabolism (2012) Vol. 62, Iss. 3, pp. 392-399
Open Access | Times Cited: 172
Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders
de Melo, Sandra Odebrecht Vargas Nunes, George Anderson, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 78, pp. 34-50
Closed Access | Times Cited: 163
Uric Acid as a Cause of the Metabolic Syndrome
Christopher R. King, Miguel A. Lanaspa, Thomas Jensen, et al.
Contributions to nephrology (2018), pp. 88-102
Closed Access | Times Cited: 162
Adiponectin Promotes Functional Recovery after Podocyte Ablation
Joseph M. Rutkowski, Zhao V. Wang, Ae Seo Deok Park, et al.
Journal of the American Society of Nephrology (2013) Vol. 24, Iss. 2, pp. 268-282
Open Access | Times Cited: 160
Page 1 - Next Page

Scroll to top